Shares of Regeneron Pharmaceuticals Inc. /zigman2/quotes/203149337/composite REGN -1.09% advanced 1.82% to $645.52 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.88% rising 2.39% to 4,023.89 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.82% rising 1.47% to 32,196.66. This was the stock's second consecutive day of gains. Regeneron Pharmaceuticals Inc. closed $101.90 short of its 52-week high ($747.42), which the company achieved on April 8th.
The stock outperformed some of its competitors Friday, as Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.29% fell 0.57% to $176.85, Novartis AG ADR /zigman2/quotes/203243705/composite NVS -0.28% rose 0.52% to $85.82, and Amgen Inc. /zigman2/quotes/209157011/composite AMGN -0.87% fell 0.54% to $243.40. Trading volume (604,530) remained 67,220 below its 50-day average volume of 671,750.